Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Which is the most appropriate diagnostic algorithm for prostate cancer screening?].

C Allepuz Losa1, A Borque Fernando, L A Rioja Sanz

  • 1Servicio de Urologia, Hospital Universitario Miguel Server, Zaragoza. callepuz@salud.aragon.es

Actas Urologicas Espanolas
|July 15, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Update and optimization of active surveillance in prostate cancer in 2021.

Actas urologicas espanolas·2020
Same author

Responses and advisability of active surveillance in prostate cancer (in response to editorial comments by Dr. Sánchez Badajoz).

Actas urologicas espanolas·2015
Same author

One of the greatest; the death of Francesc Xavier Solé Balcells (1924-2014).

Actas urologicas espanolas·2014
Same author

[Predictive models for biochemical recurrence of prostate cancer after local treatment. Nomograms].

Archivos espanoles de urologia·2012
Same author

[A new case of malignant fibrous histiocytoma arising from the renal capsule].

Actas urologicas espanolas·2010
Same author

[Steroid and xenobiotic receptor (SXR), multidrug resistance gene (MDR1) and GSTs, SULTs and CYP polymorphism expression in invasive bladder cancer, analysis of their expression and correlation with other prognostic factors].

Actas urologicas espanolas·2008

Prostate cancer screening using PSA has increased diagnoses but lacks definitive evidence for general population benefit. Personalized risk factors and individual monitoring are recommended over a universal algorithm.

Area of Science:

  • Urology
  • Oncology
  • Preventive Medicine

Context:

  • Widespread adoption of prostate-specific antigen (PSA) testing since the late 1980s has significantly increased prostate cancer diagnoses.
  • Despite indirect evidence suggesting screening benefits, robust data justifying PSA screening in the general population remain limited.
  • Significant controversy exists regarding the optimal screening algorithm for prostate cancer detection.

Purpose:

  • To review existing literature and expert experience to propose an effective algorithm for prostate cancer screening.
  • To address the lack of consensus on the best approach for PSA-based prostate cancer screening.
  • To provide guidance on prostate cancer screening strategies in light of evolving diagnostic technologies.

Summary:

  • A comprehensive literature search using terms like "prostate biopsy," "screening," "algorithms," "radical prostatectomy," "PSA," and "prostate cancer" was conducted.

Related Experiment Videos

  • Analysis reveals no single "definitive" algorithm due to rapid advancements in diagnostic tools and biomarkers.
  • Current recommendations suggest incorporating personal risk factors, including PSA levels, especially for individuals under 50, alongside rectal examinations and individualized monitoring.

    • Impact:

    • Highlights the need for validated screening algorithms tailored to specific populations.
    • Emphasizes a shift towards personalized risk assessment and monitoring in prostate cancer screening protocols.
    • Informs clinical practice and public health policy regarding the appropriate use of PSA testing for prostate cancer detection.